Behandling af peritoneale metastaser fra kolorektal cancer
(2022) In Ugeskrift for Laeger 184(31). p.1-7- Abstract
Ten per cent of patients with colorectal cancer will develop peritoneal metastases. These metastases are known to have a lesser response to systemic chemotherapy than liver- and lung metastases. Randomized studies have shown that adding cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) to this treatment gives a better chance of survival. Recently, a randomized study failed to show a difference in survival between cytoreductive surgery plus HIPEC versus cytoreductive surgery alone. These facts are summarized in this review.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/01c9b2e9-46ec-4b9d-b7cd-fb34e58a7bfb
- author
- Nielsen, Jesper Clausen and Verwaal, Victor Jilbert LU
- alternative title
- Treatment of peritoneal metastases from colorectal cancer
- publishing date
- 2022-08-01
- type
- Contribution to specialist publication or newspaper
- publication status
- published
- keywords
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Colorectal Neoplasms/pathology, Combined Modality Therapy, Cytoreduction Surgical Procedures, Humans, Hyperthermia, Induced, Peritoneal Neoplasms/drug therapy
- in
- Ugeskrift for Laeger
- volume
- 184
- issue
- 31
- pages
- 1 - 7
- publisher
- Den Almindelige Danske Lægeforening
- external identifiers
-
- pmid:35959828
- ISSN
- 0041-5782
- language
- Danish
- LU publication?
- no
- id
- 01c9b2e9-46ec-4b9d-b7cd-fb34e58a7bfb
- alternative location
- https://ugeskriftet.dk/files/scientific_article_files/2022-08/v09210707_web.pdf
- date added to LUP
- 2022-08-18 18:38:17
- date last changed
- 2022-08-19 07:12:47
@misc{01c9b2e9-46ec-4b9d-b7cd-fb34e58a7bfb, abstract = {{<p>Ten per cent of patients with colorectal cancer will develop peritoneal metastases. These metastases are known to have a lesser response to systemic chemotherapy than liver- and lung metastases. Randomized studies have shown that adding cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) to this treatment gives a better chance of survival. Recently, a randomized study failed to show a difference in survival between cytoreductive surgery plus HIPEC versus cytoreductive surgery alone. These facts are summarized in this review.</p>}}, author = {{Nielsen, Jesper Clausen and Verwaal, Victor Jilbert}}, issn = {{0041-5782}}, keywords = {{Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/pathology; Combined Modality Therapy; Cytoreduction Surgical Procedures; Humans; Hyperthermia, Induced; Peritoneal Neoplasms/drug therapy}}, language = {{dan}}, month = {{08}}, number = {{31}}, pages = {{1--7}}, publisher = {{Den Almindelige Danske Lægeforening}}, series = {{Ugeskrift for Laeger}}, title = {{Behandling af peritoneale metastaser fra kolorektal cancer}}, url = {{https://ugeskriftet.dk/files/scientific_article_files/2022-08/v09210707_web.pdf}}, volume = {{184}}, year = {{2022}}, }